Manufacturing process development of 4-HB
Active Awarded Last action
- Contract number
- 75N91025F00018
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,270,276
Award facts
- Contract value 100% obligated
- $1,270,276.00 Current and potential, with all options
- Completion date 22% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $352,570 | |
| Original award | $917,706 |
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 15, 2025, with a ceiling value of $1,270,276 for manufacturing process development of 4-HB, with ultimate completion September 14, 2030.
Place of performance is Frederick, Maryland. The order is cost-plus-fixed-fee with no set-aside. Leidos Biomedical Research operates the Frederick National Laboratory for Cancer Research on behalf of NCI and delivers specialized manufacturing work including monoclonal antibody production, gene therapy vector manufacturing, and chemistry, manufacturing, and controls development of therapeutic candidates. In FY2025, the order invoiced $23 thousand in government-paid service contract activity with no subcontractors; the prime self-performed all reported hours.
Quick answers
Who was awarded contract 75N91025F00018?
75N91025F00018 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 15, 2025.
How much is contract 75N91025F00018 worth?
The government has obligated $1,270,276 on 75N91025F00018.
Is contract 75N91025F00018 an order under another contract?
Yes. 75N91025F00018 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91025F00018 competed?
The extent of competition for 75N91025F00018 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award